Torrent Pharmaceuticals has informed that it enclosed press release issued by the Company, titled ‘Torrent Pharmaceuticals enters into co-marketing partnership with Boehringer Ingelheim India; to co- market its anti-diabetic drug and its fixed dose combinations in India‘.
The above information is a part of company’s filings submitted to BSE.